Form D · Other Health Care
Focused Genomics, Inc.
Andover, MA · CIK 0001614040
Offering snapshot reported Jul 25, 2014 · SEC filing
- Reported sold
- $420K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2014 | Initial | $420,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-221792
convertible promissory notes
Source: Form D, filed Jul 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gabor Bethlendy | Executive |
| Arindam Bhattacherjee | Director, Executive |
| George Hamilton Mehlman | Director, Executive |
| Edwin Naylor | Director |
| Dietrich Stephan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
15 Pine Tree Lane
Andover, MA, 01810
Andover, MA, 01810